Companies: 10,795·Total market cap: $144.5T
POINT Biopharma Global Inc.

POINT Biopharma Global Inc.

PNTNASDAQHealthcare
$12.50
+$0.02(+0.16%)
Market Cap$1.3B
P/E Ratio—
52W High$14.35
52W Low$6.57
SEC Filings

POINT Biopharma Global Inc. (PNT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001811764 · PNT · NASDAQ · as of Jun 9, 2026

Filing snapshot

285
Total Filings
15-12G
Latest Form
2024-01-08
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001811764 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-03-27
Fiscal Year End
Mar 27, 2023
Accession No.
0001811764-23-000007
Primary Document
pnt-20221231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001811764 · Accession 0001811764-23-000007

Latest Key Filings

10-QQuarterly Report
10-Q
2023-11-13
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2023-12-27Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2024-01-08
View
EFFECTEFFECT
EFFECT
2023-12-29
View
EFFECTEFFECT
EFFECT
2023-12-29
View
SC 13D/ASC 13D/A
SC 13D/A
2023-12-27
View
POS AMPOS AM
POS AM
2023-12-27
View
POS AMPOS AM
POS AM
2023-12-27
View
S-8 POSS-8 POS
S-8 POS
2023-12-27
View
S-8 POSS-8 POS
S-8 POS
2023-12-27
View
S-8 POSS-8 POS
S-8 POS
2023-12-27
View
25-NSE25-NSE
25-NSE
2023-12-27
View
8-KCurrent Report
FORM 8-K
2023-12-27
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2023-12-26
View
SC TO-T/ASC TO-T/A
SC TO-T/A
2023-12-26
View
SC 13D/ASC 13D/A
AMENDMENT NO. 1 TO SCHEDULE 13D
2023-12-20
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2023-12-18
View
Showing 1–15 of 213 filingsForm 4 / 144 hidden· 285 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001811764  |  Exchange: NASDAQ · Healthcare

POINT Biopharma Global Inc. (NASDAQ: PNT) has submitted 285 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001811764, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is POINT Biopharma Global Inc.'s most comprehensive regulatory disclosure. The most recent POINT Biopharma Global Inc. 10-K was filed on 2023-03-27 for fiscal year ending 2023. Historical PNT 10-K annual reports are available from 2020 through 2023.

Investors researching POINT Biopharma Global Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
CINC SEC Filings →CTIC SEC Filings →EQRX SEC Filings →VECT SEC Filings →VERV SEC Filings →PSTX SEC Filings →CBIO SEC Filings →ETHZ SEC Filings →
→ PNT Financials→ PNT Earnings→ PNT Insider Trades

Frequently Asked Questions

PNT SEC Filings · 8 questions

POINT Biopharma Global Inc. (PNT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 285 filings and access original documents at no cost. POINT Biopharma Global Inc.'s CIK is 0001811764.

PNT SEC filingsPOINT Biopharma Global Inc. SEC documentsfind PNT 10-K